Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 901
Filter
1.
Femina ; 49(5): 309-313, 20210531. ilus
Article in Portuguese | LILACS | ID: biblio-1290569

ABSTRACT

Introdução: A gravidez heterotópica é um fenômeno obstétrico muito raro em concepções espontâneas no qual gestações tópica e ectópica coexistem. O diagnóstico é difícil, mas, se realizado precocemente, o prognóstico é favorável. Descrição do caso: Paciente do sexo feminino, de 35 anos de idade, admitida com quadro de dor abdominal e pequeno sangramento vaginal. Diagnosticada precocemente e tratada cirurgicamente por gravidez heterotópica naturalmente concebida. Como resultado, a gravidez tópica seguiu sem intercorrências. Conclusão: Esse caso enfatiza a necessidade de considerar esse diagnóstico diferencial e analisar clínica e ecograficamente as características globais da pelve, mesmo na ausência de fatores de risco em gestações tópicas.(AU)


Introduction: Heterotopic pregnancy (HP) is a rare obstetric phenomenon in spontaneous conceptions in which intrauterine and ectopic pregnancies coexist. The diagnosis is difficult, but, if performed early, the prognosis is favorable. Case description: A 35-year-old woman was admitted with abdominal pain and light vaginal bleeding. She was early diagnosed and surgically treated for a naturally conceived heterotopic pregnancy. As a result, the intrauterine pregnancy went on healthily. Conclusion: This case emphasizes the need to regard HP as a differential diagnosis and analyze the global pelvis characteristics both clinically and in ultrasound scans, even in the absence of risk factors when dealing with intrauterine pregnancies.(AU)


Subject(s)
Humans , Female , Pregnancy , Pregnancy Complications/surgery , Pregnancy Complications/diagnostic imaging , Pregnancy, Tubal/surgery , Pregnancy, Tubal/diagnostic imaging , Pregnancy, Heterotopic/surgery , Pregnancy, Heterotopic/diagnostic imaging , Uterine Hemorrhage/complications , Fertilization
2.
Article in English | WPRIM | ID: wpr-880646

ABSTRACT

Heterotopic pregnancies are rare and difficult to be diagnosed early. A patient with combined intrauterine pregnancy and cervical pregnancy was admitted in Qingdao Municipal Hospital in 2019. The patient complained of abnormal vaginal bleeding after menopause and was misdiagnosed as simple intrauterine pregnancy. She underwent artificial abortion and suffered intraoperative hemorrhage. To stop bleeding, she received the treatment of uterine artery embolization immediately. Afterwards, cervical residual pregnancy tissues started necrosis, blood β-human chorionic gonadotropin level and the cervix appearance gradually returned to normal. This report suggests that cervical heterotopic pregnancy inclines to be mis diagnosed. Correct diagnosis should be made as soon as possible. Selective uterine artery embolization is an effective measure to prevent and treat massive bleeding.


Subject(s)
Chorionic Gonadotropin, beta Subunit, Human , Female , Humans , Pregnancy , Pregnancy, Heterotopic/surgery , Uterine Artery Embolization , Uterine Hemorrhage
5.
Rev. colomb. obstet. ginecol ; 71(3): 237-246, jul.-set. 2020. tab, graf
Article in Spanish | LILACS | ID: biblio-1144386

ABSTRACT

RESUMEN Objetivo: evaluar la exactitud diagnóstica del sistema de puntaje histeroscópico de cáncer endometrial. Materiales y métodos: estudio de exactitud diagnóstica ensamblado en estudio transversal, que incluyó pacientes con sangrado posmenopáusico y engrosamiento endometrial mayor o igual a 5 mm, a quienes se practicó histeroscopia, cuyo resultado se comparó con la biopsia endometrial como patrón de oro diagnóstico, en dos hospitales de alta complejidad. Se midieron variables sociodemográficas, clínicas, puntaje de evaluación histeroscópica y resultado histopatológico de tejido endometrial. En el análisis se estimó sensibilidad, especificidad, razones de probabilidades y área bajo la curva con sus respectivos intervalos de confianza. Resultados: con una prevalencia del cáncer endometrial del 9 %, el sistema de evaluación por histeroscopia mostró una sensibilidad de 75 % (IC 95 %: 30,1-95,43), especificidad de 95,1 % (IC 95 %: 83,9- 98,7), una razón de probabilidades positiva de 15,38 (IC 95 %: 3,55-66,56), una razón de probabilidades negativa de 0,26 y un área bajo la curva del 85 %. Conclusión: el sistema de evaluación endometrial histeroscópico estandarizado mostró una sensibilidad aceptable para hacer la tamización en pacientes con sangrado posmenopáusico y engrosamiento endometrial (≥ 5 mm). Se requiere la realización de estudios con un mayor tamaño muestral que permitan hacer una estimación más precisa de las características operativas de este sistema de evaluación histeroscópico para la detección de cáncer endometrial.


ABSTRACT Objective: To assess the diagnostic accuracy of hysteroscopic scores in endometrial cancer. Materials and methods: Diagnostic accuracy study assembled within a cross-sectional study that included patients with postmenopausal bleeding and endometrial thickening greater than 5 mm in whom hysteroscopy was performed and then compared with endometrial biopsy as the diagnostic gold standard, in two high complexity hospitals. Clinical, sociodemographic variables, as well as hysteroscopic scores and the results of endometrial tissue histopathology were measured. Sensitivity and specificity, likelihood ratios and area under the curve with their respective confidence intervals were estimated in the analysis. Results: With a 9 % prevalence of endometrial cancer, the hysteroscopic assessment system was shown to have 75 % sensitivity (95 % CI; 30.1- 95.43), 95,1 % specificity (95 % CI; 83.9-98.7), a positive likelihood ratio of 15.38 (95 %; CI 3.55- 66.56), a negative likelihood ratio of 0.26 and area under the curve of 85 %. Conclusion: The standardized hysteroscopic assessment system was found to have an acceptable sensitivity for screening in patients with postmenopausal bleeding and endometrial thickening (≥ 5 mm). Further studies with larger sample sizes are required in order to arrive at a more precise estimation of the operational characteristics of the hysteroscopic assessment system for the detection of endometrial cancer.


Subject(s)
Humans , Female , Middle Aged , Endometrial Neoplasms , Uterine Hemorrhage , Hysteroscopy , Postmenopause
6.
Rev. colomb. obstet. ginecol ; 71(3): 247-256, jul.-set. 2020. tab, graf
Article in Spanish | LILACS | ID: biblio-1144387

ABSTRACT

RESUMEN Objetivo: describir la seguridad y aceptabilidad del uso del sistema intrauterino liberador de levonorgestrel de 52 mg en mujeres con hemorragia uterina anormal. Materiales y métodos: cohorte retrospectiva en la que se incluyeron mujeres de 18 años o más con diagnóstico de hemorragia uterina anormal, reporte por ultrasonido de tamaño uterino entre 6 y 10 cm de longitud y cavidad endometrial uniforme en toda su longitud, independiente de alteración estructural, a quienes se les colocó para tratamiento el sistema intrauterino liberador de levonorgestrel de 52 mg, en el periodo de 2012 hasta 2016 Se realizó un muestreo por conveniencia. Se midieron variables sociodemográficas y clínicas basales, así como la percepción de la hemorragia por parte de la paciente y la frecuencia de falla, amenorrea, necesidad de histerectomía y eventos adversos, con seguimiento a 12 meses. Se aplicó estadística descriptiva. Resultados: se evaluaron 200 pacientes, hubo una percepción de mejoría subjetiva del volumen de sangrado y de la frecuencia de incapacidad laboral o asistencia a urgencias. El 90 % de las pacientes registró amenorrea y el 6 % eventos adversos. Conclusiones: el sistema intrauterino liberador de levonorgestrel de 52 mg es una alternativa segura para el manejo de la hemorragia uterina anormal en mujeres con úteros de tamaño normal y sin alteraciones submucosas del endometrio. Se requieren estudios aleatorizados en el medio local para evaluar su efectividad y eficiencia respecto a otras alternativas de manejo.


ABSTRACT Objective: To describe safety and acceptability with the use of the 52-mg levonorgestrel-releasing intrauterine system in women with abnormal uterine bleeding. Materials and methods: Retrospective cohort of women 18 years of age and older diagnosed with abnormal uterine bleeding, ultrasound-reported uterine length between 6 and 10 cm and uniform endometrial cavity in its entire length, regardless of structural abnormality, who received treatment with 52-mg levonorgestrel-releasing intrauterine system between 2012 and 2016. Non-probabilistic convenience sampling was carried out. Sociodemographic and clinical baseline variables were measured, as well as patient perception of bleeding and the frequency of failure, amenorrhea, need for hysterectomy and adverse events, over a 12-month follow-up period. Descriptive statistics were applied. Results: Overall, 200 patients were assessed. A subjective perception of improvement in terms of bleeding volume and frequency of leave of absence or visits to the emergency department was found; 90 % of the patients had amenorrhea, and 6 % experienced adverse events. Conclusions: The 52-mg levonorgestrel-releasing intrauterine system is a safe option for the management of abnormal uterine bleeding in women with normal uterine size and no submucosal endometrial abnormalities. Local randomized studies are required to assess effectiveness and efficiency in comparison with other management options.


Subject(s)
Humans , Female , Adult , Uterine Hemorrhage , Levonorgestrel , Ambulatory Care , Intrauterine Devices , Menorrhagia
7.
Univ. salud ; 22(3): 288-291, set.-dic. 2020. graf
Article in Spanish | LILACS, COLNAL | ID: biblio-1139850

ABSTRACT

Resumen Introducción: El síndrome de obstrucción hemivaginal y anomalía renal ipsilateral (OHVIRA, por sus siglas en inglés) o también llamado síndrome de Herlyn-Werner-Wunderlich es una rara malformación mulleriana que consiste en la presencia de útero didelfo, obstrucción hemivaginal y anomalía renal ipsilateral. La incidencia de malformaciones mullerianas son del 2 al 3%, y la menos común es el síndrome de OHVIRA. Objetivo: Descripción de un caso excepcional de alteraciones mullerianas poco conocido. Presentación del caso: Adolescente de 14 años con historia de dolor pélvico, dismenorrea e infecciones urinarias a repetición. Se estudió con gammagrafía renal que reveló agenesia renal derecha y resonancia magnética pélvica que mostró útero didelfo con hematocolpos derechos. Se confirmaron los hallazgos por laparoscopia diagnóstica. Conclusiones: Este síndrome es poco conocido. Debe sospecharse en casos de agenesia renal, dolor pélvico crónico y alteraciones menstruales en pacientes postpuberes. El abordaje es multidisciplinario.


Abstract Introduction: The obstructed hemivagina and ipsilateral renal anomaly (OHVIRA) syndrome, also known as the Herlyn-Werner-Wunderlich syndrome, is a rare müllerian anomaly characterized by didelphic uterus, hemivaginal obstruction, and ipsilateral renal anomaly. The incidence of müllerian malformations is 2% - 3%, OHVIRA being the least common of these cases. Objective: To describe an exceptional case of a müllerian disorder. Case presentation: A 14-year-old adolescent with a history of pelvic pain, dysmenorrhea, and recurrent urinary infections. Renal gammagraphy analysis revealed right renal agenesis, and pelvic magnetic resonance imaging showed a didelphic uterus with right hematocolpos. These findings were confirmed by diagnostic laparoscopy. Conclusions: This syndrome is not well known. Renal anegesis, chronic pelvic pain, and menstrual abnormalities in post-pubertal patients must be presumed as indicators of OHVIRA, whose treatment requires a multidisciplinary approach.


Subject(s)
Uterine Hemorrhage , Urogenital Abnormalities , Solitary Kidney
8.
Bol. méd. postgrado ; 36(1): 14-18, jul.2020. tab
Article in Spanish | LILACS, LIVECS | ID: biblio-1119375

ABSTRACT

Con el objetivo de determinar la eficacia del ácido tranexámico (AT) en la disminución del sangrado intraoperatorio en pacientes sometidas a cesárea segmentaria que ingresaron al Servicio de Emergencias Obstétricas del Hospital Central Universitario Dr. Antonio María Pineda, se realizó un estudio tipo ensayo clínico controlado, simple ciego, con una muestra de 30 pacientes distribuidas aleatoriamente en dos grupos: grupo A recibió AT 30 minutos previos a la intervención quirúrgica y el grupo B recibió cristaloides. En el grupo B se observó una discreta disminución en el valor promedio de la hemoglobina post-cesárea comparado con el valor basal. Los efectos adversos del AT fueron nauseas 53,3%, taquicardia (33,3%) y edema facial (6,6%). Ninguna paciente requirió la administración de hemoderivados durante el transoperatorio. El valor promedio de pérdidas sanguíneas observadas en los grupos con y sin AT fue de 390 ± 160,5 cc y 773,3 ± 174,9 cc, respectivamente (p = 0,000). Se concluye que la administración de AT disminuye las pérdidas sanguíneas observadas en pacientes sometidas a cesárea segmentaria(AU)


In order to determine the effectiveness of tranexamic acid (TA) in the reduction of intraoperative bleeding in patients undergoing cesarean section (C-section) admitted to the Obstetric Emergency Service of the Hospital Central Universitario Dr. Antonio Maria Pineda we performed a controlled, single blind, clinical trial with 30 patients who were randomly assigned in two groups: group A received TA and group B received crystalloids, 30 minutes before surgery. Lower mean hemoglobin post-surgery values compared to baseline were observed in the group that did not receive TA. Adverse effects of TA were nausea (53.3%), tachycardia (33.3%) and facial edema (6.6%). No patient required the administration of blood products during the transoperative period. Average observed blood losses in the AT and control groups were 390 ± 160.5 cc to 773.3 ±174.9 cc, respectively (p = 0.000). We conclude that tranexamic acid decreases observed blood losses in patients undergoing C-section(AU)


Subject(s)
Humans , Female , Tranexamic Acid/administration & dosage , Labor, Obstetric , Postpartum Hemorrhage , Intraoperative Care , Uterine Hemorrhage , Cesarean Section , Obstetrics
9.
Article in English | WPRIM | ID: wpr-876630

ABSTRACT

@#Arteriovenous malformations (AVM) are vascular disorders with a mixture of arterial, venous and small capillary-like channels with fistulous connections. Uterine arteriovenous malformations are rare cause of abnormal uterine bleeding with only a few reported cases. They may arise from pregnancy, miscarriage, previous cesarean section or other uterine surgery and gestational trophoblastic disease. Diagnosis can be made through angiography or doppler ultrasonography. Traditionally, uterine AVMs are treated with hysterectomy but with the advances in technology, minimally invasive conservative approaches such as radiologic arterial embolization or laparoscopic uterine artery ligation have become available. We present a case of a 29-year-old, G2P1 (1011) who had a three- month history of heavy, intermittent vaginal bleeding from uterine arteriovenous malformation after a miscarriage. Laparoscopic bilateral uterine artery occlusion, offered a minimally invasive treatment with high symptomatic effectiveness.


Subject(s)
Uterine Artery , Arteriovenous Malformations , Uterine Diseases , Ligation , Uterine Hemorrhage
10.
Autops. Case Rep ; 10(3): e2020144, 2020. graf
Article in English | LILACS | ID: biblio-1131832

ABSTRACT

Arteriovenous malformation (AVM) is a rare lesion in the uterus, which can lead to abnormal uterine bleeding. While AVM has been described in other organs in the literature, there is a paucity of pathology reports of the AVM in uterus. On gross examination, the uterus was markedly enlarged and partly distorted with a pedunculated solid mass, which on the cut surface showed multiple well-circumscribed hemorrhagic cysts ranging from 0.1 to 4.0 cm in size. Microscopically, they were malformed dilated vascular structures containing organized thrombi. We present this case of uterine AVM with gross and microscopic findings, which can serve as a crucial reminder for pathologists to keep in the differential diagnoses as a potential cause of abnormal uterine bleeding.


Subject(s)
Humans , Female , Pregnancy , Middle Aged , Arteriovenous Malformations/pathology , Uterine Hemorrhage/etiology , Uterus/injuries , Cysts/etiology , Diagnosis, Differential
11.
Rev. colomb. menopaus ; 26(4): 7-16, 2020.
Article in Spanish | LILACS | ID: biblio-1253123

ABSTRACT

Este es un artículo de revisión en el cual se expone la clasificación de la hemorragia uterina anormal de acuerdo a su curso clínico y su etiología según lo expuesto por la FIGO inicialmente en 2011 y revisado en 2018 con el sistema PALM-COEIN. Se desglosa cada una de las causas y se describe la manera cómo impacta el sangrado y la calidad de la vida de la mujer. Se hace énfasis en la importancia de enfocar el tratamiento de acuerdo a la causa subyacente para de esa manera evitar una posible iatrogenia.


This is a review article in which the classification of abnormal uterine bleeding is exposed according to its clinical course and etiology as presented by FIGO in 2011 and reviewed in 2018 with the PALM-COEIN system. Each of the causes is broken down and described the way they impact bleeding and quality of life. Emphasis is done in the importance of focusing treatment according to the underlying cause, and avoid possible iatrogenia.


Subject(s)
Humans , Female , Adolescent , Adult , Middle Aged , Uterine Hemorrhage , Therapeutics , Diagnosis , Iatrogenic Disease
12.
Rev. colomb. menopaus ; 26(2): 16-33, 2020.
Article in Spanish | LILACS, COLNAL | ID: biblio-1254063

ABSTRACT

Introducción: La hemorragia uterina anormal, durante la perimenopausia y la posmenopausia tiene prevalencia hasta del 35 y el 11% respectivamente. Las pacientes, en estas etapas de sus vidas, consultan por hemorragia con mucha frecuencia, viéndose enfrentadas, dentro del síndrome climatérico, a anemia, dolor pélvico, abstinencia sexual, alteraciones en compromisos sociales y profesionales y temores de sufrir enfermedades ginecológicas malignas; condiciones que afectan profundamente la calidad de vida. Es por ello que los médicos debemos estar bien preparados para tratarlas, oportunamente, tanto en consulta externa como en salas de urgencias. Objetivo: Revisar las causas de la hemorragia uterina anormal perimenopáusica y posmenopáusica y agruparlas en una clasificación coherente, a fin de facilitar su enfoque y manejo, en sus formas de presentación crónica y urgente. Material y métodos: Revisión de la literatura de los últimos 10 años, desde enero de 2010 hasta junio de 2020, en idiomas inglés y español, en libros de texto, pubMed, Ovid, Guías clínicas y Cochrane library. Resultados y conclusiones: Actualmente, contamos con buenos métodos para diagnosticar las causas de la hemorragia anormal perimenopáusica y posmenopéusica e igualmente, diferentes opciones de tratamiento para cada paciente, en particular. Las causas son benignas en su mayoría; solo hay un 10% de riesgos de cáncer endometrial. Agrupadas en una clasificación coherente, dichas causas permiten un enfoque fácil y práctico para las mejores posibilidades de tratamiento medico-quirúrgico de ellas en sus dos formas de presentación: crónica y urgente.


Introduction: Abnormal uterine bleeding during perimenopause and postmenopausal bleeding, have a prevalence of up to 35% and 11% respectively. Patients, at these stages of their lives, consult for bleeding very often facing anemia, pelvic pain, sexual abstinence, social and professional fears of malignant gynecological diseases, profoundly altering the "quality of life".That is why doctors must be well prepared to treat them, in a timely manner from bleeding, in external consultation or in emergency rooms. Objective: To review the causes of perimenopausal and postmenopausal abnormal uterine bleeding and to group them into a coherent classification, in order to facilitate their approach and management, in their chronic and urgent forms of presentation. Material and methods: Literature review of the last 10 years, from January 2010 to June 2020, in English and Spanish languages, in textbooks, PubMed, Ovid, Clinical Guides and Cochrane library. Results and conclusions: Currently, we have good methods to diagnose the causes of abnormal perimenopausal and postmenopausal bleeding; and also, different treatment options for each patient, in particular. The causes are mostly benign, there is only a 10% risk of endometrial cancer. Grouped in a coherent classification they allow an easy and practical approach, to the best medical-surgical treatment possibilities, in its two forms of presentation: chronic and urgent.


Subject(s)
Humans , Female , Adult , Middle Aged , Uterine Hemorrhage , Quality of Life , Therapeutics , Postmenopause , Perimenopause
13.
In. Verga, Federico; Burghi, Gastón. Encares de paciente crítico. Montevideo, Oficina del Libro FEFMUR, 2020. p.256-268.
Monography in Spanish | LILACS, BNUY, UY-BNMED | ID: biblio-1342652
14.
Rev. cuba. obstet. ginecol ; 45(4): e405, oct.-dic. 2019.
Article in Spanish | LILACS, CUMED | ID: biblio-1126714

ABSTRACT

RESUMEN La hemorragia uterina anormal es un término empleado para las alteraciones en la regularidad, duración y/o volumen de sangrado menstrual y es considerada una causa común de consulta médica y en ocasiones supone un reto diagnóstico para el médico tratante. Dentro del abordaje de la etiología de dicha patología, las coagulopatías afectan alrededor del 13 por ciento de las mujeres, y la más común es la enfermedad de von Willebrand. El objetivo de este trabajo fue realizar una revisión de la literatura científica actual sobre el papel que cumple la enfermedad de von Willebrand en la hemorragia uterina anormal. Esta es una patología hereditaria derivada de una deficiencia del factor von Willebrand encargado de la adhesión plaquetaria. La prevalencia de esta enfermedad puede ser baja, sin embargo, cuando se estudia la población de mujeres con menorragia, la frecuencia puede ir de 5 a 20 por ciento. Se han descrito diferentes problemas ginecológicos asociados a la enfermedad de von Willebrand, tales como menorragia, dismenorrea y una importante deficiencia de hierro asociada a esta, además de una mayor incidencia de quistes ováricos, endometriosis, hiperplasia endometrial y pólipos endometriales. La literatura actual sugiere que se realice tamizaje a aquellas mujeres con cuadro clínico sugestivo. Con respecto al tratamiento la literatura reporta el uso de ácido tranexámico y anticonceptivos orales, pero el que mayor utilidad ha demostrado es la desmopresina(AU)


ABSTRACT Abnormal uterine bleeding is a term used for alterations in the regularity, duration and / or volume of menstrual bleeding and it is considered a common cause of medical consultation; sometimes it is a diagnostic challenge for the treating physician. Within the aetiology approach of said pathology, coagulopathies affect around 13 percent of women, and the most common is von Willebrand disease. The objective is to review the current scientific literature on the influence of von Willebrand disease in abnormal uterine bleeding. This is an inherited pathology derived from a deficiency of the von Willebrand factor responsible for platelet adhesion. The prevalence of this disease may be low, however, when studying the population of women with menorrhagia, the frequency can range from 5 to 20 percent. Different gynecological problems associated with von Willebrand disease have been described, such as menorrhagia, dysmenorrhea and a significant iron deficiency associated with it, in addition to a higher incidence of ovarian cysts, endometriosis, endometrial hyperplasia and endometrial polyps. The current literature suggests that those women with suggestive clinical symptoms should be screened. Regarding treatment, the literature reports the use of tranexamic acid and oral contraceptives, nonetheless desmopressin has proven to be most useful(AU)


Subject(s)
Humans , Female , Uterine Hemorrhage/diagnosis , von Willebrand Diseases/pathology , Blood Coagulation Disorders/epidemiology , von Willebrand Factor , Ovarian Cysts/epidemiology , Review Literature as Topic
15.
Med. UIS ; 32(3): 11-17, Sep.-Dec. 2019. tab
Article in Spanish | LILACS | ID: biblio-1114972

ABSTRACT

Resumen La cicatriz uterina es un defecto en la pared anterior del miometrio secundario a la cesárea. Su prevalencia es muy variable, llegando hasta el 84% en algunos estudios, y aumenta según el número de cesáreas previas. La mayoría de las pacientes pueden ser asintomáticas, pero cuando se manifiesta es principalmente con hemorragia uterina anormal. El manejo de esta patología se ha descrito mediante técnicas farmacológicas y quirúrgicas, siendo más estudiadas las técnicas quirúrgicas, dentro de las que se encuentran la histeroscopía, laparoscopia, laparoscopia asistida con histeroscopía, laparotomía y el abordaje vaginal. Se realizó una revisión en PubMed-MEDLINE y LILACS respecto al manejo de este defecto, tomándose artículos publicados en los últimos cinco años, en la cual se encontraron 37 artículos. El manejo depende principalmente de factores como la sintomatología de la paciente, si tiene paridad satisfecha o no, la profundidad del defecto y las preferencias de la paciente. MÉD.UIS.2019;32(3):11-7


Abstract The postcesarean scar defect is a defect in the anterior wall of the myometrium secondary to the cesarean section. Its prevalence is variable, reaching up to 84% in some studies, increasing with the number of previous cesarean sections. Most of the patients can be asymptomatic, but when it manifests, is mostly with abnormal uterine bleeding. Its management has been described with pharmacological and surgical techniques, the latter being the most researched. They include the hysteroscopy, laparoscopy, laparotomy, and the vaginal approach. A revision in PubMed-MEDLINE and LILACS about the management of this defect was done, including articles published in the last five years, resulting in 37 articles. The selection of the treatment depends on different factors such as the patient's symptoms, if she has satisfied parity or not, the depth of the defect and the patient's preferences. MÉD.UIS.2019;32(3):11-7


Subject(s)
Humans , Female , Cesarean Section , Cicatrix , Parity , Pathology , Patients , Therapeutics , Uterine Hemorrhage , Hysteroscopy , Laparoscopy , Gynecology , Laparotomy , Myometrium
16.
Int. j. cardiovasc. sci. (Impr.) ; 32(3): 297-301, May-June 2019. graf
Article in English | LILACS | ID: biblio-1002228

ABSTRACT

Uterine leiomyoma and coronary artery disease are two common diseases in women. However, the association of uterine bleeding caused by leiomyoma with unstable coronary syndrome is not frequent. Here we describe a case of a patient with active vaginal bleeding and unstable angina who underwent a unique approach by performing percutaneous procedures. The report demonstrates that new interventional options can be used to control active bleeding in patients in need of coronary angioplasty


Subject(s)
Humans , Female , Adult , Uterine Hemorrhage/complications , Women , Stents , Angioplasty , Platelet Aggregation Inhibitors/therapeutic use , Angioplasty, Balloon, Coronary/methods , Embolization, Therapeutic/methods , Leiomyoma
17.
Article in Chinese | WPRIM | ID: wpr-813053

ABSTRACT

To investigate the clinical value of vaginal endoscopy in the diagnosis and treatment for vaginal and uterine diseases in young girls and adolescent girls. 
 Methods: The clinical data of 156 young girls and adolescent girls treated with vaginoscopy from February 2000 to August 2017 were analyzed retrospectively.
 Results: Of the 37 cases of young girls, the clinical symptoms were the most common in vaginal hemorrhage, accounting for 40.5% (15 cases), the second one in vaginal foreign body, accounting for 29.7% (11 cases), the third one in abnormal vaginal secretion, accounting for 24.3% (9 cases), and the last one in low abdominal pain, accounting for 5.4% (2 cases). The final diagnosis of vaginal foreign body was 13 cases (35.1%). Of the 119 adolescent girls, the clinical symptoms of the visit were the most common in menstrual abnormalities or irregular vaginal bleeding, accounting for 75.6% (90 cases). The final diagnosis of abnormal uterine bleeding-ovulatory dysfunction was the most common with 59 cases (49.6%), following by 16 cases of abnormal uterine bleeding-polyp, 2 cases of abnormal uterine bleeding-malignancy and hyperplasia, and 1 cases of abnormal uterine bleeding-coagulopathy. There were 37 cases (31.1%) of reproductive tract malformation. All 156 patients successfully completed vaginal endoscopy and operation with only 1 case of urinary system infection. No other complications occurred and no damage in the hymen. 
 Conclusion: Vaginal endoscopy is a safe, effective and near-noninvasive way for the diagnosis and treatment of vaginal or uterine diseases in young girls and adolescent girls. In the case of abnormal vaginal secretions and vaginal bleeding, it should be properly recommended to use the vaginal endoscopy for diagnosis and treatment.


Subject(s)
Adolescent , Endoscopy , Female , Foreign Bodies , Humans , Retrospective Studies , Uterine Hemorrhage , Vagina
18.
Article in Chinese | WPRIM | ID: wpr-775879

ABSTRACT

OBJECTIVE@#To compare the clinical efficacy between acupuncture artificial menstrual cycle method and medication artificial menstrual cycle method for abnormal uterine bleeding-ovulatory (AUB-O) dysfunction (spleen deficiency syndrome).@*METHODS@#Sixty patients were randomly assigned into an observation group and a control group, 30 cases in each one. 3 cases dropped out in the observation group and 27 cases were included into analysis; 2 cases dropped out in the control group and 28 cases were included into analysis. The patients in the observation group were treated with acupuncture artificial menstrual cycle method. The acupoints were selected according to different stages of menstrual cycle. The acupuncture was given for 30 min per treatment, once every other day; no treatment was given during menstrual period. Xuehai (SP 10), Sanyinjiao (SP 6), Taixi (KI 3), Guanyuan (CV 4), Qihai (CV 6), Zusanli (ST 36) and Zhangmen (LR 13) were selected after menstrual period. Taichong (LR 3), Hegu (LI 4), Yaoyangguan (GV 3), Geshu (BL 17), Ganshu (BL 18), Sanyinjiao (SP 6), Pishu (BL 20) were selected in ovulaton periods. Baihui (GV 20), Shenshu (BL 23), Yaoyangguan (GV 3), Geshu (BL 17), Sanyinjiao (SP 6), Zusanli (ST 36), Gongsun (SP 4) were selected before menstrual period. The patients in the control group were treated with medication artificial menstrual cycle method. Femoston (estradiol tablets/estradiol dydrogesterone tablets) was taken orally. The white tablets were estradiol (1 mg), while the gray tablets were estradiol (1 mg) and dydrogesterone (10 mg). The Femoston was taken once a day, white tablets for the first 14 days, then gray tablets for the last 14 days. The 28-day treatment was taken as one session, and one cycle menstrual was taken as one treatment course, and totally 3 courses were given in the two groups. The clinical symptom score was observed before and after treatment as well as in follow-up visit (3 months after treatment). The clinical efficacy was evaluated based on the total effective rate, the marked effective rate of main symptoms (including menstrual cycle, menstrual period, menstrual volume) and basal body temperature (BBT).@*RESULTS@#① Compared before treatment, the clinical symptom score in the two groups was decreased after treatment and in the follow-up visit (0.05). Compared with the control group, the clinical symptom score in the follow-up visit as well as the difference of that between pre-treatment and follow-up visit had significant difference in the observation group (0.05). ③ After treatment, the marked effective rate of menstrual cycle, menstrual period, menstrual volume had no significant difference between the two groups (>0.05); during the follow-up visit, the marked effective rate of menstrual cycle in the observation group was superior to that in the control group (0.05). ④ After treatment, the diphasic curve rate of BBT had no significant difference between the two groups (>0.05); during the follow-up visit, the diphasic curve rate of BBT in the observation group was higher than that in the control group (<0.05).@*CONCLUSION@#Acupuncture artificial menstrual cycle method has superior efficacy for AUB-O dysfunction (spleen deficiency syndrome), which has similar efficacy with medication artificial menstrual cycle method. Moreover, acupuncture has advantages in regulating menstrual cycle and improving ovulation, and has a longer curative effect.


Subject(s)
Acupuncture Therapy , Female , Humans , Menstrual Cycle , Treatment Outcome , Uterine Hemorrhage , Therapeutics
19.
Article in English | WPRIM | ID: wpr-719671

ABSTRACT

Cervical varix is rare and can develop due to various conditions in pregnancy. Most cases of cervical varix during pregnancy are diagnosed in the second or third trimester and are usually associated with abnormal placental location, such as placenta previa or low-lying placenta. A 23-year-old woman with cervical varix bleeding visited our institution at 8 weeks of gestation. This case report describes cervical varix bleeding that developed into a venous thrombus in the first trimester. Ultrasonography with color Doppler and magnetic resonance imaging could be helpful in diagnosis.


Subject(s)
Diagnosis , Female , Hemorrhage , Humans , Magnetic Resonance Imaging , Placenta , Placenta Previa , Pregnancy , Pregnancy Trimester, First , Pregnancy Trimester, Third , Pregnancy , Thrombosis , Ultrasonography , Uterine Hemorrhage , Varicose Veins , Young Adult
20.
Article in English | WPRIM | ID: wpr-742005

ABSTRACT

In the reproductive age, many women have several uterine myomas and present with abnormal uterine bleeding, dysmenorrhea, and occasionally infertility. There are three surgical approaches to perform myomectomy, including robotic-assisted, laparoscopic, and abdominal myomectomy. Compared to laparoscopic procedures, robotic myomectomy allows free approach of myoma bases using fine instruments and endoscopes. Fine uterine wall sutures can be performed layer-by-layer with robots. However, robotic surgery is difficult to perform because there is no sense of touch during the operation. We report two clinical myomectomy cases with replaced lack of haptic feedback during robot surgery. The patients received robotic myomectomy with/without right ovarian cystectomy and adhesiolysis. Sixty-five leiomyomas were removed in case 1. Forty-six leiomyomas were removed in case 2. Lack of haptic feedback is replaced by more developed visual sense during robot myomectomy of multiple tiny intramural myomas, and robotic surgery can be performed much more effectively even in complicated cases.


Subject(s)
Cystectomy , Dysmenorrhea , Endoscopes , Female , Humans , Infertility , Leiomyoma , Myoma , Robotic Surgical Procedures , Sutures , Uterine Hemorrhage , Uterine Myomectomy
SELECTION OF CITATIONS
SEARCH DETAIL